.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Covington
Federal Trade Commission
Moodys
Novartis
Cipla
US Department of Justice
Fish and Richardson
McKinsey
Boehringer Ingelheim

Generated: September 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018933

« Back to Dashboard
NDA 018933 describes M.V.I.-12 LYOPHILIZED, which is a drug marketed by Teligent Pharma Inc and is included in one NDA. Additional details are available on the M.V.I.-12 LYOPHILIZED profile page.

The generic ingredient in M.V.I.-12 LYOPHILIZED is ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine; riboflavin 5'-phosphate sodium; thiamine; vitamin a; vitamin e. There are six drug master file entries for this compound. Additional details are available on the ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine; riboflavin 5'-phosphate sodium; thiamine; vitamin a; vitamin e profile page.

Summary for NDA: 018933

You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'SODIUM','THIAMINE','VITAMIN A','VITAMIN E') AND hsdb_drugname IS NOT NULL' at line 1
Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0